People
Felix Werth's path into longevity science began from a deeply personal place: a fear of death that emerged in childhood and a profound desire to escape the fate of dying — regardless of the cause, including aging. In early 2012, at age 33, while researching cryonics, he discovered a talk by Dr. Aubrey de Grey. The presentation introduced him to the idea that aging is the accumulation of cellular and molecular damage — damage that is likely repairable. For Felix, this was a turning point. It was the first time he saw a real chance to prevent death from aging within his own lifetime.
Motivated by this realization, he left his previous path behind and committed himself fully to the cause. As a first concrete step, he returned to university to study biochemistry to make a contribution to this mission. He holds a Master's degree in Electrical and Computer Engineering (with a focus on integrated circuit design) and later earned a Bachelor's degree in Biosciences, specializing in biochemistry. This interdisciplinary background combines engineering skills with a grounding in biology, equipping him to contribute to the development of rejuvenation medicine.
During his biochemistry studies, Felix realized just how slow progress in laboratory research can be — a general challenge in biomedical science. He also became aware of how underfunded the field of anti-aging research is, with too few scientists working in parallel on the problem. Since developing therapies to reverse aging likely requires thousands of different drugs targeting a wide array of molecular and cellular damage, he concluded that, unless the scale of research is significantly expanded, it is unlikely that progress will occur fast enough to benefit his own generation. He recognized that increased public funding would enable more scientists to work on these challenges, thereby increasing the likelihood of timely breakthroughs. This led him to conclude that his personal contribution could be more impactful through public outreach and advocacy, helping grow the movement and attract the support needed to accelerate progress.
In 2015, he initiated a single-issue political party in Germany focused solely on promoting rejuvenation research. Originally launched as the Partei für Gesundheitsforschung, it is now called the Partei für Verjüngungsforschung (Party for Rejuvenation Research).
Under Felix's leadership, the party has participated in over 20 elections at the European, federal, and state levels — raising awareness of the possibilities of accelerating the development of medical solutions for age-related degeneration. His work has included nationwide outreach campaigns, street-level engagement, and extensive media coverage. Interviews and articles featuring Felix can be found across various platforms.
Today, Felix is building Fix Aging AI with the goal of contributing to the development of rejuvenation medications through the application of artificial intelligence. While the company is still in its early stages, it reflects his ambition to build one of the leading companies in this field. He is currently seeking investment in order to assemble a dedicated team and accelerate drug discovery for currently unaddressed causes of aging-related decline.
Felix's commitment remains deeply personal. He isn't driven by status or profit — he is fighting for his own survival. For him, the mission is clear: to contribute to the global effort to overcome aging and help ensure that therapies arrive not only for future generations, but for himself — and for as many people alive today as possible.